Delivery Order SPE2DR25D1202-SPE2DR26F71VB
Award Date 10/30/25
Potential Completion Date 11/21/25
Potential Value $7.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,117.48 by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of Xeomin 100 Unit Vials. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 28, 2025, and represents a child order under a larger contract vehicle. The award carries no set-aside designation, reflecting open...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 14, 2025, for the supply of Xeomin 200 Unit Vials valued at $93,868.32, with completion scheduled for August 4, 2025. This competitively awarded, firm fixed-price delivery order was issued by the Medical Supply Chain division of the Defense Logistics Agency and carries no set-aside designation. The contract reflects the Defense Department's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a $93,868.32 firm fixed-price delivery order for 200-unit vials of Xeomin on October 17, 2025, with an ultimate completion date of November 7, 2025. This non-competitive delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $59,699.64 by the Defense Logistics Agency (DLA) on August 6, 2025. The contract, utilizing firm fixed-price pricing, covers the supply of Xeomin 100 unit vials and is scheduled for completion by August 27, 2025. The award was made through open competition with no set-aside designation, with performance taking place at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.48 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Xeomin 200 Unit Vials. This firm fixed-price delivery order, with an ultimate completion date of October 16, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive, non-set-aside procurement action and is issued under AmerisourceBergen's existing Indefinite Delivery...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,174.80 by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Xeomin 100 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and represents a non-competitive set-aside award. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,234.96 to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Xeomin 100 unit vials. The contract utilizes firm fixed pricing and is scheduled for completion by November 7, 2025. This is an unset-aside, competitively awarded delivery order, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $70,401.24 on September 17, 2025, for the supply of Xeomin 200 Unit Vials. This firm fixed-price contract, with an ultimate completion date of October 8, 2025, was awarded without a set-aside designation through competitive procurement. The award is funded by the Defense Logistics Agency's Medical Supply Chain, reflecting the Department of...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Xeomin 200 unit vials, with a ceiling value of $13,409.76 and a firm fixed price structure. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 20, 2025. Performance will be executed from the contractor's Corporate Office location in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,174.80 on August 15, 2025, for the supply of Xeomin 100 Unit Vials. This firm fixed-price, non-set-aside contract is scheduled for completion by September 8, 2025, and is being funded through the Defense Medical Supply Chain, which supports pharmaceutical procurement for military and veteran healthcare systems. The award represents a child delivery order under...